Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
文献类型：期刊论文
| 作者 | Dai, Yang1; Ji, Yichun1; Shen, Yanyan1; Su, Yi1; Liu, Bo1; Wang, Yueliang1; Sun, Deqiao1; Jiang, Yuchen1; Zha, Chuantao2; Xie, Zuoquan1
|
| 刊名 | CANCER IMMUNOLOGY RESEARCH
 |
| 出版日期 | 2020-03-01 |
| 卷号 | 8期号:3页码:70-70 |
| ISSN号 | 2326-6066 |
| WOS研究方向 | Oncology ; Immunology |
| 语种 | 英语 |
| WOS记录号 | WOS:000518188200112 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/281514]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.Shanghai Inst Mat Med, Shanghai, Peoples R China 2.Shanghai HaiHe Pharmaceut Co Ltd, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Dai, Yang,Ji, Yichun,Shen, Yanyan,et al. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.[J]. CANCER IMMUNOLOGY RESEARCH,2020,8(3):70-70. |
| APA | Dai, Yang.,Ji, Yichun.,Shen, Yanyan.,Su, Yi.,Liu, Bo.,...&Chen, Yi.(2020).Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models..CANCER IMMUNOLOGY RESEARCH,8(3),70-70. |
| MLA | Dai, Yang,et al."Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.".CANCER IMMUNOLOGY RESEARCH 8.3(2020):70-70. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。